# Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

> **NCT00069953** · PHASE2 · COMPLETED · sponsor: **Radiation Therapy Oncology Group** · enrollment: 43 (actual)

## Conditions studied

- Esophageal Cancer

## Interventions

- **BIOLOGICAL:** filgrastim
- **BIOLOGICAL:** pegfilgrastim
- **DRUG:** cisplatin
- **DRUG:** fluorouracil
- **DRUG:** paclitaxel
- **PROCEDURE:** conventional surgery
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00069953
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** 2007-03
- **Final completion:** 2016-12
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2017-02-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00069953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00069953, "Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00069953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*